The Race to the Top: Does China Have What it Takes?

Season 4, Episode 3,   Feb 07, 2021, 12:00 PM

China’s regulatory reforms and policy enhancements bode well for a thriving biosimilars industry.

You can read more about China’s market by clicking here or here. 
For information on Bio-Thera, click here.
For information on Shanghai Henlius Biotech, click here.
Subscribe
Next
Podcast logo
Steven Lucio Discusses BI’s Citizen Petition and the Current Status of Biosimilars
Top Episodes